Does Probiotic Blood Lipids Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Probiotic Blood Lipids Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background Cardiovascular diseases, driven significantly by dyslipidemia, remain a leading global mortality risk. [Zuo J (2025); evidence level 1] - plantarum supplementation significantly reduced TC (SMD: -0.233; 95% CI: -0.458, -0.008; p = 0.042), TG (SMD: -0.227; 95% CI: -0.432, -0.021; p = 0.030), and LDL-C (SMD: -0.251; 95% CI: -0.477, -0.025; p = 0.029), but not HDL-C. [Zuo J (2025); evidence level 1] - plantarum ), which is a probiotic commonly used in a variety of food products, may contribute to the regulation of blood lipids, although prior studies report inconsistent efficacy and lack mechanistic clarity. [Zuo J (2025); evidence level 1] - Background Emerging evidence suggests gut microbiota modulation may influence neurocognitive function through the gut-brain axis. [Huang J (2025); evidence level 2] - The findings may inform the development of strategies to delay cognitive decline by modulating the gut-brain axis in this high-risk population. [Huang J (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.